Managing aggressive behavior in patients with obsessive-compulsive disorder and borderline personality disorder

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Obsessive-compulsive disorder (OCD) is one of the most common psychiatric disorders, occurring in 2% to 3% of the U.S. population. Borderline personality disorder is found in 2% of the U.S. population. These disorders denote the endpoints on a spectrum of compulsive and impulsive disorders. One endpoint marks compulsive or risk-aversive behaviors characterized by overestimation of the probability of future harm, highlighted by OCD. The other endpoint designates impulsive action characterized by the lack of complete consideration of the negative results of such behavior, such as borderline and antisocial personality disorders. This article examines studies testing the efficacy of different medications in treating compulsive and impulsive disorders. Mood stabilizers such as divalproex, selective serotonin reuptake inhibitors, monoamine oxidase inhibitors, and neuroleptics have documented efficacy in treating aggression and affective instability in impulsive patients.

Original languageEnglish (US)
Pages (from-to)38-44
Number of pages7
JournalJournal of Clinical Psychiatry
Volume60
Issue numberSUPPL. 15
StatePublished - 1999
Externally publishedYes

Fingerprint

Borderline Personality Disorder
Obsessive-Compulsive Disorder
Antisocial Personality Disorder
Monoamine Oxidase Inhibitors
Serotonin Uptake Inhibitors
Valproic Acid
Aggression
Antipsychotic Agents
Population
Psychiatry

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Clinical Psychology

Cite this

@article{d5995d0c1c394961b31cb8e71aaa80a8,
title = "Managing aggressive behavior in patients with obsessive-compulsive disorder and borderline personality disorder",
abstract = "Obsessive-compulsive disorder (OCD) is one of the most common psychiatric disorders, occurring in 2{\%} to 3{\%} of the U.S. population. Borderline personality disorder is found in 2{\%} of the U.S. population. These disorders denote the endpoints on a spectrum of compulsive and impulsive disorders. One endpoint marks compulsive or risk-aversive behaviors characterized by overestimation of the probability of future harm, highlighted by OCD. The other endpoint designates impulsive action characterized by the lack of complete consideration of the negative results of such behavior, such as borderline and antisocial personality disorders. This article examines studies testing the efficacy of different medications in treating compulsive and impulsive disorders. Mood stabilizers such as divalproex, selective serotonin reuptake inhibitors, monoamine oxidase inhibitors, and neuroleptics have documented efficacy in treating aggression and affective instability in impulsive patients.",
author = "Eric Hollander",
year = "1999",
language = "English (US)",
volume = "60",
pages = "38--44",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "SUPPL. 15",

}

TY - JOUR

T1 - Managing aggressive behavior in patients with obsessive-compulsive disorder and borderline personality disorder

AU - Hollander, Eric

PY - 1999

Y1 - 1999

N2 - Obsessive-compulsive disorder (OCD) is one of the most common psychiatric disorders, occurring in 2% to 3% of the U.S. population. Borderline personality disorder is found in 2% of the U.S. population. These disorders denote the endpoints on a spectrum of compulsive and impulsive disorders. One endpoint marks compulsive or risk-aversive behaviors characterized by overestimation of the probability of future harm, highlighted by OCD. The other endpoint designates impulsive action characterized by the lack of complete consideration of the negative results of such behavior, such as borderline and antisocial personality disorders. This article examines studies testing the efficacy of different medications in treating compulsive and impulsive disorders. Mood stabilizers such as divalproex, selective serotonin reuptake inhibitors, monoamine oxidase inhibitors, and neuroleptics have documented efficacy in treating aggression and affective instability in impulsive patients.

AB - Obsessive-compulsive disorder (OCD) is one of the most common psychiatric disorders, occurring in 2% to 3% of the U.S. population. Borderline personality disorder is found in 2% of the U.S. population. These disorders denote the endpoints on a spectrum of compulsive and impulsive disorders. One endpoint marks compulsive or risk-aversive behaviors characterized by overestimation of the probability of future harm, highlighted by OCD. The other endpoint designates impulsive action characterized by the lack of complete consideration of the negative results of such behavior, such as borderline and antisocial personality disorders. This article examines studies testing the efficacy of different medications in treating compulsive and impulsive disorders. Mood stabilizers such as divalproex, selective serotonin reuptake inhibitors, monoamine oxidase inhibitors, and neuroleptics have documented efficacy in treating aggression and affective instability in impulsive patients.

UR - http://www.scopus.com/inward/record.url?scp=0032838652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032838652&partnerID=8YFLogxK

M3 - Article

C2 - 10418814

AN - SCOPUS:0032838652

VL - 60

SP - 38

EP - 44

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - SUPPL. 15

ER -